KSR-001-03

DRUG2 trials

Sponsors

Kukje Pharma

Conditions

Dry Eye Syndromes

Phase 1

[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001

CompletedNCT05017870

Kukje PharmaDry Eye Syndromes

Start: 2018-12-02End: 2020-01-15Updated: 2021-08-24

Phase 2

[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome

CompletedNCT05017844

Kukje PharmaDry Eye Syndromes

Start: 2020-02-18End: 2021-06-22Updated: 2021-08-24